Chest CT Using Low-concentration Iodine Contrast Media

• Status: Recruiting
• Trial end date: 2024-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to evaluate the quality of images when low-concentration iodine contrast agents is used in chest CT with low tube voltage and if they can be used in routine imaging.

The primary endpoint of the study was the quality of the image and comparison of chest CT by using low and conventional concentration iodine contrast agents with low tube voltage and chest CT by using the conventional concentration iodine contrast agents with the conventional tube voltage; The secondary endpoint is optimizing chest CT protocol using an iodine contrast agent.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jung Im Jung
• Collaborator: Taejoon Pharmaceutical Co., Ltd.

Criteria

Inclusion Criteria:

• Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone

Exclusion Criteria:

1. Under the age of 18

2. Cases where contrast-enhanced CT cannot be performed

3. Heart failure

4. Pregnancy

5. If patients cannot voluntarily give written consent to participate in this clinical trial

6. In the case of an anatomical deformation that may interfere with image analysis in the previous image

7. Patients with a history of hypersensitivity to IOBRIX, components of IOBRIX, and iodine-based drugs

8. Patients with severe thyroid disease (Iodine may accumulate in the thyroid gland and worsen symptoms.)

9. Those who are judged unsuitable by the tester for other reasons Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone